Glass House Brands (GLAS) Non Operating Investment Income (2021 - 2022)
Glass House Brands (GLAS) posted quarterly Non Operating Investment Income of -$3.3 million for Q4 2022, down 70.19% year-over-year from -$11.1 million in Q4 2021, and down 100.0% quarter-over-quarter from $871.3 billion in Q3 2022.
Glass House Brands (GLAS) Non Operating Investment Income (2021 - 2022) Analysis & Trends
Glass House Brands (GLAS) has reported Non Operating Investment Income for 2 consecutive years, with -$3.3 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Non Operating Investment Income fell 70.19% year-over-year to -$3.3 million; the TTM figure through Dec 2022 stood at $1298.0 billion (up 52.22% YoY), while the FY2022 annual figure was -$2.0 million, down 132.95% from the prior year.
- Non Operating Investment Income retreated to -$3.3 million in Q4 2022 per GLAS's latest filing, from $871.3 billion in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $871.3 billion in Q3 2022 and bottomed at -$3.3 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Glass House Brands | 840.76 Mn | 822.21 Mn | 15.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3.30 Mn |
| Dec 31, 2022 | -3.30 Mn |
| Sep 30, 2022 | 871.33 Bn |
| Sep 30, 2022 | 871.33 Bn |
| Jun 30, 2022 | 426.66 Bn |
| Jun 30, 2022 | 426.66 Bn |
| Mar 31, 2022 | 353,659.00 |
| Mar 31, 2022 | 353,659.00 |
| Dec 31, 2021 | -1.94 Mn |
| Dec 31, 2021 | -1.94 Mn |
| Sep 30, 2021 | 568.47 Bn |
| Sep 30, 2021 | 568.47 Bn |
| Jun 30, 2021 | 284.25 Bn |
| Jun 30, 2021 | 284.25 Bn |
| Mar 31, 2021 | 6.09 Mn |
| Mar 31, 2021 | 6.09 Mn |